Insurers, courts grapple with when to pay for wilderness therapy; major abortion pill maker hires its first lobbyists

Parents are suing insurers to get them to cover wilderness therapy, an industry that's itself trying to recover from a sordid past. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Insurers, courts grapple with how and when to pay for wilderness therapy — a polarizing industry with a sordid past By Tara Bannow RHONA WISE/AFP via Getty Images Parents are suing insurers to get them to cover wilderness therapy, an industry that's itself trying to recover from a sordid past. Read More Major abortion pill maker GenBioPro hires its first lobbyists in Washington By Nicholas Florko Allen G. Breed/AP The main manufacturer of the abortion pill mifepristone hired its own team of lobbyists for the first time this summer. Read More STAT+: UnitedHealthcare to offer $0 insulin, Epi-Pens, but only for some members By Bob Herman and Tara Bannow Michael M. Santiago/Getty Images Next year, United will offer employer health plans that have no copays or out-of-pocket costs for five vital drugs, including insulin. Read More Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis ⁠— at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. Opinion: Monkeypox patients should not be left to suffer when an FDA-approved drug could help By Jay K. Varma and Joseph Osmundson Karen Ducey/Getty Images Tecovirimat (TOPXX), an FDA-approved drug, can be used to treat monkeypox. But it's almost impossible for people with the disease to get it. Read More Opinion: Congress: Don't let hospital care at home shrivel when the public health emergency ends By Stephen Parodi and Ceci Connolly Arturo Holmes/Getty Images Hospital care at home is effective and rated highly by those who need it. Congress needs to guarantee that it is here to stay. Read More Friday, July 15, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser